Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Luoyang Jianlong Micro-nano New Materials Co., Ltd. Class A (688357.SS)
Luoyang, LN, CN
Luoyang Jianlong Micro-nano New Material Co., Ltd engages in the manufacture and sale of molecular sieves in China. The company’s products include molecular sieve raw powder, molecular sieve activation powder, molding zeolite, special molecular sieves, activated alumina. It also produces and sells of adsorption and catalytic materials for use in industrial gas separation, medical oxygen, energy chemical industry, petrochemical industry, renewable resources, and renewable energy. In addition, it sells industrial sodium chloride, as well as provides technical services. The company was founded in 1998 and is based in Luoyang, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.57% | -3.06% | +0.03% | +4.77% | -12.88% | +5.60% | +37.40% | -39.41% | -25.78% | +38.44% | +38.44% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+8.0% ★ Q1'26: +2.3% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+44.1% ★ Q1'26: -34.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+7.4% Q1'26: -1.2% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+12.9% ★ Q1'26: +12.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+5.1% Q1'26: +4.7% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-8.6% ★ Q1'26: -0.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×5.87× Q1'26: 9.35× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
451.55M
est: 477.55M (-5.4%)
|
877.65M
est: 896.67M (-2.1%)
|
853.79M
est: 853.33M (+0.1%)
|
972.24M
est: 850.79M (+14.3%)
|
778.75M
est: 864.00M (-9.9%)
|
840.85M
est: 826.00M (+1.8%)
|
1.69B
1.69B – 1.69B
+105.0% YoY
|
2.09B
2.09B – 2.09B
+23.7% YoY
|
| EBITDA |
175.14M
est: 147.65M (+18.6%)
|
350.27M
est: 277.23M (+26.3%)
|
261.42M
est: 263.83M (-0.9%)
|
234.51M
est: 232.09M (+1.0%)
|
160.32M
est: 235.69M (-32.0%)
|
177.93M
est: 225.33M (-21.0%)
|
461.84M
461.84M – 461.84M
+105.0% YoY
|
571.23M
571.23M – 571.23M
+23.7% YoY
|
| EBIT |
152.36M
est: 119.36M (+27.6%)
|
318.31M
est: 224.12M (+42.0%)
|
217.08M
est: 213.28M (+1.8%)
|
176.23M
est: 177.45M (-0.7%)
|
90.45M
est: 180.21M (-49.8%)
|
108.06M
est: 172.28M (-37.3%)
|
353.12M
353.12M – 353.12M
+105.0% YoY
|
436.76M
436.76M – 436.76M
+23.7% YoY
|
| Net Income |
127.37M
est: 108.63M (+17.3%)
|
275.41M
est: 327.84M (-16.0%)
|
197.86M
est: 216.82M (-8.7%)
|
153.03M
est: 124.83M (+22.6%)
|
74.76M
est: 105.56M (-29.2%)
|
98.52M
est: 101.54M (-3.0%)
|
203.08M
203.08M – 203.08M
+100.0% YoY
|
256.36M
256.36M – 256.36M
+26.2% YoY
|
| SGA |
44.71M
est: 22.54M (+98.4%)
|
76.12M
est: 42.32M (+79.8%)
|
75.09M
est: 40.28M (+86.4%)
|
96.71M
est: 76.94M (+25.7%)
|
109.71M
est: 78.14M (+40.4%)
|
31.25M
est: 74.70M (-58.2%)
|
153.11M
153.11M – 153.11M
+105.0% YoY
|
189.38M
189.38M – 189.38M
+23.7% YoY
|
| EPS |
1.31
est: 0.99 (+32.6%)
|
2.83
est: 2.98 (-5.1%)
|
2.00
est: 1.97 (+1.4%)
|
1.53
est: 1.24 (+23.2%)
|
0.75
est: 1.05 (-28.6%)
|
0.98
est: 1.01 (-3.0%)
|
2.02
2.02 – 2.02
+100.0% YoY
|
2.55
2.55 – 2.55
+26.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chaoyang Guo | Vice President & Director | — | male |
| Jingtao Zhang | Financial Director | — | female |
| Lujie Yu | Accounting Supervisor | — | — |
| Pu Bai | General Manager, Technical Director & Director of the R&D Center | — | male |
| Ti Gao | Secretary of the Board | — | male |
| Yan Xia Guo | Senior Engineer | — | female |
| Yan Zhang | Head of Internal Audit Department | — | male |
| Yi Cheng Li | Vice Chairman & President | — | male |
| Yi Dan Li | Vice President & Director | — | female |
| Yu Feng Wang | Deputy General Manager of Jianyang Technology | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 688357.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
